CorMedix Inc. - 8-K Filing
CorMedix enters into Asset Purchase Agreement to acquire substantially all assets of Heron Therapeutics for $145.0 million in cash, 14.58 million shares of common stock, and contingent earn-outs. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure)
Tickers: $CRMD
Read the full article at SEC EDGAR
Part of the story Imunon, Inc. - 8-K Filing (38 articles)